| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5603029 | Heart, Lung and Circulation | 2016 | 11 Pages |
Abstract
Percutaneous LAA occlusion is a reasonably efficacious and safe therapeutic option in patients with NVAF who are at high risk for stroke and contraindicated for long-term anticoagulation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Haiyan MD, Xiongwei PhD, Bingjian MD, Shuren BD, Fang PhD,